Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo Strikes Deal With Indian Firm To Track Social Media
Reuters, India
Monday, March 19, 2012 - 9:24am
tags:
India, GSK, social media, Infosys
Cardiome provides update on Merck's development plans for Vernakalant Oral
The Fly on the Wall
Monday, March 19, 2012 - 9:22am
tags:
Cardiome, Merck, Vernakalant, atrial fibrillation
Johnson & Johnson Joins the Shareholder Revolution
Forbes
Monday, March 19, 2012 - 9:20am
tags:
JNJ, shareholders
Ampio says eye drug shows promise in trial
Reuters
Monday, March 19, 2012 - 9:20am
tags:
Ampio Pharmaceuticals, eye health, diabetes, Optina
China Biotech In Review: Cloud Hangs Over Pharmaceutical Industry Over Cost-Cutting
Seeking Alpha
Sunday, March 18, 2012 - 11:32am
tags:
China Biotech, InflammaGen Therapeutics, Boehringer Ingelheim, Bayer, Sihuan Pharmaceutical
Teva reports favorable Laquinimod trial results
Globes, Israel
Sunday, March 18, 2012 - 11:30am
tags:
Teva Pharmaceuticals, laquinimod, multiple sclerosis
Roche Sees Limited Rebound in Global Drug Market, Le Temps Says
Bloomberg
Sunday, March 18, 2012 - 11:27am
tags:
Roche
9 Pharma Buys for a Healthy Portfolio
Investor Place
Sunday, March 18, 2012 - 11:26am
tags:
Novo Nordisk, Valeant Pharmaceuticals, GSK, Abbott Laboratories, Eli Lilly, JNJ, Pfizer, Merck, Sanofi
Biotechs Have No Business in This Indication
Motley Fool
Sunday, March 18, 2012 - 11:23am
tags:
Anthera, acute coronary syndrome
Pfizer: Dividend Dynamo or the Next Blowup?
Motley Fool
Sunday, March 18, 2012 - 11:21am
tags:
Pfizer
Some Healthy Respect for Novartis, Please
Barron's
Saturday, March 17, 2012 - 12:39pm
tags:
Novartis
Aptalis Pharma Begins Promotion of RECTIV(TM) to Physicians in the U.S.
Health Care Global
Saturday, March 17, 2012 - 12:38pm
tags:
Aptalis, Rectiv, anal fissure
Amerigen files ANDA for generic version of Bystolic with US FDA
Pharmabiz
Saturday, March 17, 2012 - 12:19pm
tags:
Amerigen Pharma
SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation
news-medical.net
Saturday, March 17, 2012 - 12:18pm
tags:
SK Biopharmaceuticals, YKP10811, constipation
Deals worth $1.75 billion offer insight into Abbott's spinoff strategy
Chicago Tibune, IL
Saturday, March 17, 2012 - 12:16pm
tags:
Abbott Laboratories
6 Pharmaceuticals Paying 3%
Seeking Alpha
Saturday, March 17, 2012 - 12:10pm
tags:
Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly, JNJ, Merck, Pfizer
OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
Bradenton Herald, FL
Saturday, March 17, 2012 - 12:06pm
tags:
OncoGenex
For Biotech Firms, Gravy Days Are Over
WSJ
Saturday, March 17, 2012 - 11:41am
tags:
Salix Pharmaceuticals, Ltd. : Salix Pharmaceuticals Closes Sale of Convertible Notes
4-Traders
Saturday, March 17, 2012 - 11:39am
tags:
Salix
Study finds ties to drugmakers on mental health panel
U-T San Diego, CA
Saturday, March 17, 2012 - 11:38am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.